OrthoIQ, Inc. raised $1,080,000 (Cambridge, MA)

LIVE PUBLIC DATA Source: SEC EDGAR Form D filings (U.S. Securities and Exchange Commission) · Last refreshed: Wed, 04 Nov 2026 01:28:40 GMT

OrthoIQ, Inc. plus every comparable record, with all columns and source links, as one CSV.

Not investment advice and not an offer or solicitation to buy or sell any security.

63 / 100 vendor spend propensity

Estimated post-raise budget for CPA / Tax / Audit services: $21,600 (heuristic)

  • Operating company: new capital typically funds hiring, facilities and vendors.
  • Raised $1,080,000 so far.
  • Healthcare & Life Sciences companies are a strong fit for CPA / Tax / Audit services.
  • New filing (not an amendment): the raise is fresh.
FieldValue
IndustryBiotechnology (Healthcare & Life Sciences)
Operating companyYes
Exemption506(b)
Amount sold$1,080,000
Total offering$1,400,000
Investors so far25
First sale2022-06-20
Filed2026-10-23
EntityCorporation

Executives and related persons (from the filing)

  • Audrey Chen: Executive Officer, Director
  • Alan Davidner: Director
  • Phillip Merritt: Director

View the filing on SEC EDGAR

Markdown version

OrthoIQ, Inc. vs. top 3 peers

OrganizationLocationCapital raisedRecord date
OrthoIQ, Inc.Cambridge$1,080,0002026-10-23
Tru Singular Health, Inc.Natick$1,000,0002026-10-30
511 Therapeutics, Inc.Cambridge$500,0002026-10-30
Accufy Diagnostics, Inc.Rockville$2,000,0002026-10-28

Related records

Newly funded companies in Massachusetts (SEC Form D) Newly funded Healthcare & Life Sciences companies (SEC Form D)

Get new raises like this every morning

FormDPulse emails you newly funded companies that match your ideal customer profile.

See plans

Often used together

Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.